PHILADELPHIA and LONDON, March 11 /PRNewswire/ --

- Unique Survey Shows Much Room for Originator Pharmaceutical Companies to Improve Their Understanding of Generic Competition

The Healthcare and Science business of Thomson Reuters today released the white paper, The Five Myths of Generic Competition, highlighting what originator pharmaceutical and biotech companies can do to improve their forecasting of the likely timing, source and intensity of competition from generic drugs.

The findings in this white paper are based on an independent survey of commercial professionals in pharmaceutical and biotech companies. The research was conducted by Thomson Reuters during May and June 2008.

LONDON, March 11 /PRNewswire/ --

New research released to mark No Smoking Day (11 March) shows more than one in three (36%) of the nine million smokers in Great Britain are thinking about or planning to cut down or quit as a direct result of the economic downturn. The poll also shows that one in ten (9%) will be taking the first step and making a quit attempt on No Smoking Day.

No Smoking Day President and Dragons' Den star, Duncan Bannatyne, commented on the findings: Everybody is feeling the pinch during the current recession.

For smokers, who can spend over GBP2000 a year on cigarettes, it's particularly tough, so for those who are ready to quit there has never been a better time.

This statement about natural selection is the last sentence of Adaptation and Natural Selection, George Williams' masterpiece about evolution. George Williams is one of the unsung heroes of 20th century science. An evolutionary biologist I know (who shall remain anonymous to spare him/her public shaming) claimed not to know who was George Williams. I was/still am aghast. This anonymous evolutionary biologist is the inspiration for this post, indeed for my series of citation classics (see also here).

SAN FRANCISCO, March 10 /PRNewswire/ -- In the news release, Double Fusion Promotes Noam Korin to Vice President of Advertising Sales, Europe issued on 10 Mar 2009 08:00 GMT by Double Fusion over PR Newswire, we are advised by the company that the third paragraph quotation should be attributed to Jonathan Epstein. The complete, corrected release follows:

Double Fusion Promotes Noam Korin to Vice President of Advertising Sales, Europe

NEW ORLEANS, March 10 /PRNewswire/ --

ZSL, a leading ISV Global Software Solutions and Services provider, launches Mobile Power (http://www.zslinc.com/MS-Dynamics-CRM-Add-on-Solutions.html) and Business Power (http://www.zslinc.com/MS-Dynamics-CRM-Add-on-Solutions.html), a suite of add-ons for Microsoft Dynamics CRM, GP and NAV.

(LOGO: http://www.newscom.com/cgi-bin/prnh/20080602/NEM131LOGO )

ZSL will be demonstrating their Mobile Power and Business Power products suite, at the Microsoft Convergence 2009 event held in New Orleans, LA between March 10-13 at Booth #233. ZSL is the first one to release the add-ons to enable comprehensive mobile access to the MS Dynamics products.

PISCATAWAY, New Jersey, March 10 /PRNewswire/ --

- Event Features Panel Discussion on Technologies That Will Change the Way Humans Interact with Machines, the World and Each Other

IEEE, the world's largest technical professional society, today spotlighted seven technologies it believes will have world changing implications on the way humans interact with machines, the world and each other, in honor of its 125th anniversary.

On 10 March 2009 at the New Yorker Hotel in New York City, a panel of technology experts, moderated by The New York Times senior editor and technology reporter Steve Lohr, discussed emerging technologies in fields ranging from biometrics, computing, wireless power, and others, that they believe have the potential to change the world.

EINDHOVEN, The Netherlands, March 10 /PRNewswire/ -- The Center for Translational Molecular Medicine (CTMM) - the Dutch public-private partnership committed to the research and development of new techniques for the diagnosis and treatment of major diseases - today announced that eight new research projects will receive funding from the CTMM. It means that almost 250 million Euros have now been allocated to Netherlands-based translational projects that could radically improve patient outcomes for diseases such as Alzheimer's, rheumatoid arthritis, sepsis, cardiovascular disorders and the most important forms of cancer.

WALTON-ON-THAMES, England, March 10 /PRNewswire/ --

- Dramatically Reduces Capital and Operational Costs Associated With Document and Data Transformation, Content Archiving and eDelivery

Xenos Group Inc. (TSX: XNS) today launched Xenos OnLine(TM), a complete line-up of Software-as-a-Service (SaaS) offerings that deliver Xenos' award- winning core technology and solutions on demand. Xenos OnLine provides frustrated line-of-business and IT managers whose document and data projects are stalled due to IT budget constraints, a zero-capital solution that resolves immediate information management issues and assures rapid time-to- market.

MENLO PARK, California, March 10 /PRNewswire/ --

- Use of the MitraClip(R) System Continues to Expand in the European Union

Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first series of patients have been successfully treated with the MitraClip(R) system at the Cardiocentro Ticino in Lugano, Switzerland. The MitraClip(R) system is the only medical device commercially available in the European Union which provides a non-surgical mitral valve repair option for patients suffering from the effects of functional and degenerative mitral regurgitation (MR).

The European Kidney Health Alliance (EKHA) and World Kidney Day (WKD) organisations today call for action at EU level to support early awareness, identification and treatment of CKD and its associated diseases such as cardiovascular disease (CVD), hypertension (high blood pressure) and diabetes. The MEP Group for Kidney Health, launched on WKD last year, met at the European Parliament in Strasbourg today with an eminent panel of renal experts, politicians, and patient and kidney organisations. The meeting relayed the stark message that unchecked high blood pressure may severely damage the kidneys and is a major cause of CKD.